Keith D Kaufman Selected Research

Keith D Kaufman Research Topics

Disease

49	Type 2 Diabetes Mellitus (MODY) 01/2022 - 02/2008
22	Hypoglycemia (Reactive Hypoglycemia) 04/2018 - 02/2008
13	Body Weight (Weight, Body) 11/2017 - 04/2007
8	Alopecia (Baldness) 09/2012 - 01/2002
6	Weight Loss (Weight Reduction) 10/2017 - 10/2006
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2013
4	Stroke (Strokes) 12/2019 - 12/2013
4	Myocardial Infarction 12/2019 - 12/2013
3	Overweight 01/2022 - 10/2006
3	Constipation 01/2021 - 04/2010
3	Renal Insufficiency (Renal Failure) 10/2020 - 05/2013
3	Heart Failure 11/2017 - 07/2015
3	Weight Gain 10/2017 - 05/2013
3	Diarrhea 01/2017 - 04/2010
2	Hip Fractures (Intertrochanteric Fractures) 12/2019 - 01/2017
2	Unstable Angina 04/2017 - 12/2013
2	Pancreatitis 04/2017 - 01/2013
2	Nausea 01/2017 - 04/2010
1	Virilism (Virilization) 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Back Pain (Backache) 01/2021
1	Human Influenza (Influenza) 01/2021
1	Nasopharyngitis 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Osteoporosis 12/2019
1	Atrial Fibrillation 12/2019
1	Postmenopausal Osteoporosis 12/2019
1	Bone Resorption 12/2019
1	Disease Progression 11/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2017
1	Vomiting 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Osteoporotic Fractures 01/2017
1	Edema (Dropsy) 09/2016
1	Chronic Renal Insufficiency 05/2013
1	Cellulitis 04/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2013
1	Headache (Headaches) 04/2013
1	Neoplasms (Cancer) 01/2013
1	Flushing 04/2010
1	Hypertriglyceridemia 01/2005
1	Hypertension (High Blood Pressure) 01/2005
1	Glucose Intolerance 01/2005
1	Insulin Resistance 01/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2005
1	Dyslipidemias (Dyslipidemia) 01/2005
1	Obesity 01/2005
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2003

Drug/Important Bio-Agent (IBA)

39	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 02/2008
19	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 02/2008
9	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 04/2018 - 11/2015
8	Finasteride (Propecia)FDA LinkGeneric 09/2012 - 01/2002
7	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2017 - 03/2015
7	Hypoglycemic Agents (Hypoglycemics)IBA 11/2017 - 10/2008
5	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 08/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2005
4	Glipizide (Glucotrol)FDA LinkGeneric 05/2013 - 07/2011
3	Insulin (Novolin)FDA Link 01/2022 - 12/2011
3	Insulin Glargine (Lantus)FDA Link 01/2019 - 12/2011
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2016 - 09/2013
3	Hemoglobins (Hemoglobin)IBA 12/2013 - 03/2013
3	trans- N- (1- (2- fluorophenyl)- 1h- pyrazol- 3- yl)- 1'- oxo- spiro(cyclohexane- 1,3'(1'H)- furo(3,4- C)pyridine)- 4- carboxamideIBA 08/2007 - 10/2006
2	AutoantibodiesIBA 01/2022 - 01/2022
2	ipragliflozinIBA 01/2021 - 01/2021
2	dapagliflozinIBA 10/2020 - 12/2018
2	glimepiride (Amarel)FDA LinkGeneric 11/2017 - 10/2017
2	Pioglitazone (Actos)FDA Link 09/2016 - 03/2013
2	N- (3- (4- chlorophenyl)- 2- (3- cyanophenyl)- 1- methylpropyl)- 2- methyl- 2- ((5- (trifluoromethyl)pyridin- 2- yl)oxy)propanamideIBA 12/2010 - 04/2010
2	Neuropeptide YIBA 08/2007 - 04/2007
2	neuropeptide Y5 receptorIBA 08/2007 - 10/2006
1	Testosterone (Sustanon)FDA Link 01/2022
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2022
1	human follicle stimulating hormone with HCG C-terminal peptideIBA 01/2022
1	GonadotropinsIBA 01/2022
1	Cathepsin KIBA 12/2019
1	odanacatibIBA 12/2019
1	SodiumIBA 12/2018
1	omega-Chloroacetophenone (Mace)IBA 11/2017
1	Acarbose FDA LinkGeneric 01/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 11/2015
1	antineoplaston A10 (A 10)IBA 05/2013
1	Rosiglitazone (Avandia)FDA Link 03/2013
1	3- ((6- (ethylsulfonyl)- 3- pyridinyl)oxy)- 5- (2- hydroxy- 1- methylethoxy)- N- (1- methyl- 1H- pyrazol- 3- yl)benzamideIBA 12/2011
1	GlucokinaseIBA 12/2011
1	Triglycerides (Triacylglycerol)IBA 12/2011
1	Hemoglobin AIBA 02/2008
1	Orlistat (Xenical)FDA Link 08/2007
1	sibutramine (Meridia)FDA Link 08/2007
1	Hormones (Hormone)IBA 08/2007
1	HDL CholesterolIBA 01/2005
1	LipidsIBA 01/2005
1	Nonesterified Fatty Acids (NEFA)IBA 01/2005
1	AndrogensIBA 12/2002
1	Dihydrotestosterone (Androstanolone)IBA 04/2002

Therapy/Procedure

19	Glycemic Control 01/2022 - 01/2009
17	Therapeutics 01/2022 - 06/2003
2	Caloric Restriction 12/2010 - 04/2007
2	Aftercare (After-Treatment) 07/2006 - 04/2002
1	Precision Medicine 01/2022
1	Drug Therapy (Chemotherapy) 12/2010